Branch-duct intraductal papillary mucinous neoplasm (IPMN): Are cyst volumetry and other novel imaging features able to improve malignancy prediction compared to well-established resection criteria?Show others and affiliations
2022 (English)In: European Radiology, ISSN 0938-7994, E-ISSN 1432-1084, Vol. 32, no 8, p. 5144-5155Article in journal (Refereed) Published
Abstract [en]
Objectives: Current guidelines base the management of intraductal papillary mucinous neoplasms (IPMN) on several well-established resection criteria (RC), including cyst size. However, malignancy may occur in small cysts. Since branch-duct (BD) IPMN are not perfect spheres, volumetric and morphologic analysis might better correlate with mucin production and grade of dysplasia. Nonetheless, their role in malignancy (high-grade dysplasia/invasive cancer) prediction has been poorly investigated. Previous studies evaluating RC also included patients with solid-mass-forming pancreatic cancer (PC), which may affect the RC yield. This study aimed to assess the role of volume, morphology, and other well-established RC in malignancy prediction in patients with BD- and mixed-type IPMN after excluding solid masses.
Methods: Retrospective ethical review-board-approved study of 106 patients (2008–2019) with histopathological diagnosis of BD- and mixed-type IPMN (without solid masses) and preoperative MRI available. Standard imaging and clinical features were collected, and the novel imaging features cyst-volume and elongation value [EV = 1 − (width/length)] calculated on T2-weighted images. Logistic regression analysis was performed. Statistical significance set at two-tails, p < 0.05.
Results: Neither volume (odds ratio (OR) = 1.01, 95% CI: 0.99–1.02, p = 0.12) nor EV (OR = 0.38, 95% CI: 0.02–5.93, p = 0.49) was associated with malignancy. Contrast-enhancing mural nodules (MN), main pancreatic duct (MPD) ≥ 5 mm, and elevated carbohydrate antigen (CA) 19-9 serum levels (> 37 μmol/L) were associated with malignancy (MN OR: 4.32, 95% CI: 1.18–15.76, p = 0.02; MPD ≥ 5 mm OR: 4.2, 95% CI: 1.34–13.1, p = 0.01; CA19-9 OR: 6.72; 95% CI: 1.89 – 23.89, p = 0.003).
Conclusions: Volume and elongation value cannot predict malignancy in BD- and/or mixed-type IPMN. Mural nodules, MPD ≥ 5 mm and elevated CA19-9 serum levels are associated with higher malignancy risk even after the exclusion of solid masses. Key Points: • Novel and well-established resection criteria for IPMN have been evaluated after excluding solid masses. • BD-IPMN volume and elongation value cannot predict malignancy. • Main pancreatic duct ≥ 5 mm, mural nodules, and elevated carbohydrate antigen 19-9 levels are associated with malignancy.
Place, publisher, year, edition, pages
Springer Science+Business Media B.V., 2022. Vol. 32, no 8, p. 5144-5155
Keywords [en]
Cysts, Logistic models, Magnetic resonance imaging, Pancreatic carcinoma, Pancreatic intraductal neoplasm
National Category
Radiology, Nuclear Medicine and Medical Imaging
Research subject
Surgery
Identifiers
URN: urn:nbn:se:umu:diva-193232DOI: 10.1007/s00330-022-08650-5ISI: 000767722600002PubMedID: 35275259Scopus ID: 2-s2.0-85126107554OAI: oai:DiVA.org:umu-193232DiVA, id: diva2:1646040
Funder
Region Stockholm
Note
Pozzi Mucelli, R.M., Moro, C.F., Del Chiaro, M. et al. Publisher Correction: Branch-duct intraductal papillary mucinous neoplasm (IPMN): Are cyst volumetry and other novel imaging features able to improve malignancy prediction compared to well-established resection criteria?. Eur Radiol (2022). DOI: 10.1007/s00330-022-09309-x
2022-03-212022-03-212025-06-05Bibliographically approved